Abatix (Dallas, Texas) has entered into an agreement with Moore Medical (New Britain, Connecticut), a specialty marketer and distributor of medical, surgical and pharmaceutical products to healthcare professionals in non-hospital settings. Abatix and Moore Medical will become affiliate partners, allowing each company to better serve their customers with an expanded product offering and industry expertise. Under this agreement, both companies will offer a broad line of products in the safety, domestic preparedness and medical categories.

Altea Therapeutics (Tucker, Georgia) has entered into a two-year Cooperative Research and Development Agreement (CRADA) with the Centers for Disease Control and Prevention (CDC, Atlanta, Georgia) to evaluate the Altea Therapeutics PassPort delivery system for the delivery of influenza antigens to immune cells near the skin surface. Under the agreement, scientists at the CDC and Altea Therapeutics will evaluate the use of the PassPort system to deliver influenza protein and gene-based antigens to induce, augment and/or broaden the overall protective immune response to influenza viruses of similar or different subtypes. Work performed under the CRADA will evaluate this vaccine delivery strategy in animal models. Altea uses its PassPort system to deliver protein and peptide drugs, small-molecule drugs, genes and vaccines from a skin patch, to improve therapeutic utility and eliminate the need for needle injections.

GE Medical Systems Information Technologies (GEMSIT; Milwaukee, Wisconsin) signed an agreement with Wheaton Franciscan Services (Wheaton, Illinois). Wheaton Franciscan will install GE's Centricity picture archiving and communications system (PACS) throughout its organization, marking the first time it has contracted for a systemwide clinical information technology. The initial installation will include Covenant Healthcare System (Milwaukee, Wisconsin), All Saints Healthcare System (Racine, Wisconsin) and Covenant Health System (Waterloo, Iowa). GE's Centricity PACS solution will integrate with McKesson's Horizon hospital information systems environment to provide a seamless flow of information throughout the system. Wheaton Franciscan is the parent organization for more than 100 health and shelter service organizations in Colorado, Illinois, Iowa and Wisconsin. It includes 16 hospital campuses, four long-term care facilities, two home health agencies, 70 clinic sites and nearly 3,000 units of assisted living and other housing.

Predictive medicine company IMI International Medical Innovations (Toronto, Ontario) has signed a collaborative research agreement with AtheroGenics (Alpharetta, Georgia). IMI's cardiovascular risk assessment test, Cholesterol 1,2,3, will be added to AtheroGenics' international ARISE trial, providing IMI with primary event data and broad exposure to cardiac centers around the world. The Phase III ARISE study (Aggressive Reduction of Inflammation Stops Events) will be conducted in more than 180 cardiac centers throughout the U.S., Canada, the UK and South Africa. ARISE is designed to evaluate the impact of AGI-1067, an oral anti-inflammatory agent developed by AtheroGenics to target atherosclerosis. The study will enroll 4,000 patients who will be followed for an average of 18 months or until a minimum of 1,160 primary events have occurred, such as heart attack or stroke. Cholesterol 1,2,3 is the world's only non-invasive test system for cholesterol. It measures cholesterol in the skin, by placing two drops of liquid on the palm of the hand and generating a color-change reaction.

LCA-Vision (Cincinnati, Ohio), a provider of laser vision correction services under the LasikPlus brand, has signed an agreement with the OptiCare Eye Health Network (Rocky Mount, North Carolina). The agreement provides OptiCare's 2 million covered benefit lives with immediate access to LCA-Vision's National Lasik Network at reduced pricing. OptiCare Eye Health Network is a unit of OptiCare Health Systems (Waterbury, Connecticut), an integrated eye care services company providing vision benefits management services to a broad range of health plans, employer groups and trade associations across the country. LCA-Vision owns and operates 33 LasikPlus facilities in the U.S., plus two centers in Canada and a joint venture in Europe.

Novare Surgical Systems (Cupertino, California), a privately held provider of devices for cardiovascular and vascular surgery, has entered into a multiple-year supply agreement with Boston Scientific (Natick, Massachusetts). Boston Scientific will purchase specially modified models of Novare's Intrack line of atraumatic surgical clamps and market them as part of its new Cobra Bipolar System, used to treat atrial fibrillation using radiofrequency waves

Quinton Cardiology Systems (Bothell, Washington) and QRS Diagnostic (Plymouth, Minnesota), a maker of software-based medical devices contained on computer cards, announced a strategic partnership under which Quinton will sell several QRS devices for cardiopulmonary diagnosis under the Burdick brand name. Burdick, a Quinton subsidiary since January 2003, is a provider of cardiology products and is recognized for its distribution network focused on physicians' offices. Burdick will sell QRS PC card devices, including Universal ECG, SpiroCard and SpirOxCard, as well as the Sensaire hand-held spirometer, beginning in 3Q03.